New York Eye and Ear Infirmary of Mount Sinai, 150 East 32nd Street #102, New York, NY, USA.
Drugs. 2015 Jul;75(11):1177-85. doi: 10.1007/s40265-015-0432-8.
Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of lid hygiene dates back to the 1950s, when selenium sulfide-based shampoo was first used to treat seborrhoeic dermatitis of the eyelids. Today, tear-free baby shampoo has replaced dandruff shampoo for MGD treatment and offers symptom relief in selected patients. However, many will not achieve significant improvement on this therapy alone; some may even develop an allergy to the added dyes and fragrances in these products. Other manual and mechanical techniques to treat MGD include MG expression and massage, MG probing and LipiFlow(®). While potentially effective in patients with moderate MGD, these procedures are more invasive and may be cost prohibitive. Pharmacological treatments are another course of action. Supplements rich in omega-3 fatty acids have been shown to improve both MGD and dry eye symptoms. Tea tree oil, specifically the terpenin-4-ol component, is especially effective in treating MGD associated with Demodex mites. Topical antibiotics, such as azithromycin, or systemic antibiotics, such as doxycycline or azithromycin, can improve MGD symptoms both by altering the ocular flora and through anti-inflammatory mechanisms. Addressing and treating concurrent ocular allergy is integral to symptom management. Topical N-acetylcysteine and topical cyclosporine can both be effective therapeutic adjuncts in patients with concurrent dry eye. A short course of topical steroid may be used in some severe cases, with monitoring for steroid-induced glaucoma and cataracts. While the standard method to treat MGD is simply warm compresses and baby shampoo, a more tailored approach to address the multiple aetiologies of the disease is suggested.
睑板腺(MG)功能障碍(MGD)是一种多因素的慢性眼睑疾病,可导致眼部刺激、炎症和眼表面疾病。初始保守治疗通常包括热敷,此外还可以使用婴儿洗发水或眼睑擦拭物。眼睑卫生的做法可以追溯到 20 世纪 50 年代,当时首次使用基于硒硫化物的洗发水来治疗眼睑脂溢性皮炎。如今,无泪婴儿洗发水已取代头皮屑洗发水用于 MGD 治疗,并为选定的患者提供症状缓解。然而,许多患者仅靠这种治疗无法取得显著改善;有些患者甚至可能对这些产品中添加的染料和香料产生过敏。其他治疗 MGD 的手动和机械技术包括 MG 表达和按摩、MG 探查和 LipiFlow(®)。虽然这些方法在中度 MGD 患者中可能有效,但它们更具侵入性,并且可能成本过高。药物治疗是另一种治疗方法。富含欧米伽-3 脂肪酸的补充剂已被证明可以改善 MGD 和干眼症症状。茶树油,特别是萜烯-4-醇成分,在治疗与螨虫相关的 MGD 方面特别有效。局部抗生素,如阿奇霉素,或全身抗生素,如多西环素或阿奇霉素,通过改变眼表菌群和抗炎机制,都可以改善 MGD 症状。解决和治疗并存的眼部过敏是症状管理的重要组成部分。局部 N-乙酰半胱氨酸和局部环孢素在伴有干眼症的患者中都可以作为有效的治疗辅助剂。在一些严重的情况下,可以使用短期局部类固醇治疗,但需要监测类固醇引起的青光眼和白内障。虽然治疗 MGD 的标准方法仅是热敷和婴儿洗发水,但建议采用更具针对性的方法来解决该疾病的多种病因。